Libor Kostka

19PUBLICATIONS
44CO-AUTHORS
NanomaterialsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Polymerisation mechanismsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 06, 2026
Engineered etoposide-prednisolone co-nanocrystals for synergistic antitumor efficacy enhancement.

|Apr 21, 2026
CD64-Targeted Polymer-Drug Conjugates Exploit Cathepsin K-Dependent Payload Release for Selective Elimination of Immunosuppressive Macrophages.

|Mar 19, 2026
Charge-Shifting Copolymers of 2‑(N,N‑Dimethylamino)Ethyl Acrylate and 2‑Hydroxyethyl Acrylate via RAFT Polymerization: Balancing the Charge Content and Biological Response.

Radoslava Sivkova, Monika Matiyani, Gabriela S García-Briones

|Jan 19, 2026
Lopinavir Derivative as Potent P-gp Inhibitor Enables Delivery through HPMA Copolymer Conjugates and Overcoming Tumor Chemoresistance to Conventional Cytostatic Drugs.

Daniil Starenko, Libor Kostka, Katerina Behalova

|Nov 13, 2025
Nanomedicines for Delivery of Cytarabine: Effect of Carrier Structure and Spacer on the Anti-Lymphoma Efficacy.

Robert Pola, Eliška Grosmanová, Michal Pechar

|Nov 04, 2024
Precise Control of Molecular Weight Characteristics of Charge-Shifting Poly(2-(N,N-Dimethylamino)Ethylacrylate) Synthesized by Reversible Addition-Fragmentation Chain Transfer Polymerization.

Radoslava Sivkova, Rafal Konefal, Libor Kostka

Pageof 4

Frequent Collaborators

14 joint publications

Tomáš Etrych

3 joint publications

Marek Kovář

2 joint publications

Rafal Konefal

2 joint publications

Jan Konvalinka